title: IMP-1 carbapenemase detected in an Acinetobacter clinical isolate from the UK.
authors.forename: Luke
authors.initials: L
authors.lastname: Tysall
authors.forename: Mark W
authors.initials: MW
authors.lastname: Stockdale
authors.forename: Paul R
authors.initials: PR
authors.lastname: Chadwick
authors.forename: Marie-France I
authors.initials: MF
authors.lastname: Palepou
authors.forename: Kevin J
authors.initials: KJ
authors.lastname: Towner
authors.forename: David M
authors.initials: DM
authors.lastname: Livermore
authors.forename: Neil
authors.initials: N
authors.lastname: Woodford
mesh_terms: D000150:Acinetobacter / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics / Q000302:isolation & purification*; D000151:Acinetobacter Infections / Q000188:drug therapy / Q000382:microbiology*; D001426:Bacterial Proteins; D006801:Humans; D015378:Imipenem / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D013845:Thienamycins / Q000494:pharmacology; D001618:beta-Lactamases / Q000235:genetics* / Q000302:isolation & purification
chemical_list: D001426:Bacterial Proteins; D013845:Thienamycins; D015378:Imipenem; C409201:beta-lactamase IMP-1; D001618:beta-Lactamases; C063912:carbapenemase